SS
CRMD icon

SBI Securities’s CorMedix CRMD Stock Holding History

SBI Securities’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$69.3K Sell
8,831
-2,441
-22% -$19.3K ﹤0.01% 1052
2026
Q1 		$76.5K Buy
11,272
+1,346
+14% +$9.95K ﹤0.01% 933
2025
Q4 		$115K Buy
9,926
+450
+5% +$4.97K ﹤0.01% 797
2025
Q3 		$110K Buy
9,476
+793
+9% +$9.59K ﹤0.01% 824
2025
Q2 		$107K Sell
8,683
-2
-0% -$22 ﹤0.01% 796
2025
Q1 		$53.5K Buy
8,685
+7,599
+700% +$78.7K ﹤0.01% 951
2024
Q4 		$8.8K Buy
+1,086
New +$10.8K ﹤0.01% 1696

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

SBI Securities's CRMD Position: Q2 2026 in Review

SBI Securities reduced its CorMedix (CRMD) stake by 22% in Q2 2026, selling an estimated $19.3K and leaving 8,831 shares worth $69.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1052.

SBI Securities first reported a position in CRMD in Q4 2024 and has held it in 7 quarters since. The position peaked at $115K in Q4 2025. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • SBI Securities held 8,831 shares of CorMedix worth $69.3K as of Q2 2026.
  • SBI Securities sold 2,441 CorMedix shares in Q2 2026, an estimated $19.3K.
  • CorMedix made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #1052 holding.
  • SBI Securities first reported a position in CorMedix in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's CorMedix position peaked at $115K in Q4 2025.
  • 194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.